Newswise — CHICAGO, March 15, 2012 /PRNewswire-USNewswire/ -- Provocative and practice-changing research in the field of gynecologic cancers will be presented at The Annual Meeting on Women's Cancer — conducted by the Society of Gynecologic Oncology (SGO), to be held March 24-27, 2012, at the Austin Convention Center, Austin, TX. Over 400 studies will be presented at the meeting.
Some key highlights are listed below:
Featured Abstract #1: (Embargoed for coverage until presentation on March 27, 2012) The SGO 2012 Presidential Outstanding Abstract Award will be presented for "Disparities in Epithelial Ovarian Cancer According to Race and Socioeconomic Status: Adherence to National Comprehensive Cancer Network Guidelines and Survival Outcome a Study of 47,160 Patients from the National Cancer Data Base" by Robert E. Bristow, MD, University of California - Irvine Medical Center, et. al.
In this study, analysis of outcomes for 47,160 women treated for ovarian cancer between 1998 and 2002 found that race and socioeconomic factors, including insurance status and household income, correlated with poorer outcome as demonstrated by decreased five-year-survival rates for certain groups of women. This study focuses on the important issue of disparities in health care. Fewer than half of all women in the study received treatment that adhered to National Comprehensive Cancer Network (NCCN) guidelines, a set of guidelines developed by an alliance of the world's leading cancer centers that make treatment recommendations based on the best evidence available. African American patients and women who were on Medicare or not insured, regardless of race, were less likely to receive NCCN-adherent care.
Research Brief available at: http://www.sgomeetingsonwomenscancer.com/#!media/vstc9=media-resources
Late-Breaking Abstract #2: (Embargoed for coverage until presentation on March 25, 2012)
A second noteworthy abstract is "Randomized Phase III Noninferiority Trial of First Line Chemotherapy for Metastatic or Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study" David Scott Miller, M.D., University of Texas Southwestern Medical Center, et. al.
This phase III trial, conducted by the Gynecologic Oncology Group, enrolled 1,341 women and demonstrates that a less toxic two-drug regimen is not less effective than a standard three-drug regimen. Included in this study is an important quality of life component that demonstrated less toxicity with the two-drug regimen when compared to the two-drug regimen.
Research Brief available at: http://www.sgomeetingsonwomenscancer.com/#!media/vstc9=media-resources
About The 43rd Annual Meeting on Women's Cancer®
The Annual Meeting will feature more than 400 scientific presentations in addition to lectures, workshops, symposia, surgical and education forums and interactive debates that focus on emerging science, clinical trials and treatment in the field of gynecologic oncology. The programming covers surgical disease management, comprehensive multidisciplinary treatment, preventative medicine and scientific research.
Visit our meeting website at: http://www.sgomeetingsonwomenscancer.com
About the SGO
The Society of Gynecologic Oncology (SGO) is a national medical specialty organization of physicians and allied healthcare professionals who are trained in the comprehensive management of women with malignancies of the reproductive tract. Its purpose is to improve the care of women with gynecologic cancer by encouraging research, disseminating knowledge that will raise the standards of practice in the prevention and treatment of gynecologic malignancies, and cooperating with other organizations interested in women's health care, oncology and related fields. The Society's membership, totaling more than 1,400, is primarily comprised of gynecologic oncologists, as well as other related medical specialists including medical oncologists, radiation oncologists, nurses, social workers and pathologists. SGO members provide multidisciplinary cancer treatment including chemotherapy, radiation therapy, surgery and supportive care. More information on the SGO can be found at www.sgo.org.
MEDIA RESOURCES: Media Attendance at Annual Meeting: Media are welcome to attend all or parts of the Annual Meeting. Please visit this link for more information on meeting details and how to register for the meeting and secure media credentials. http://www.sgomeetingsonwomenscancer.com/#!media
Abstract Download Site: The following link shows all available abstracts. Working media may request a complementary copy by contacting SGO Media Relations with the name of the requested abstract. http://www.sciencedirect.com/science/journal/00908258
Interview Opportunities: Please contact SGO Media Relations to schedule on-site or telephone interviews with any of the abstract authors. We will do our best to comply with all requests.
RSS